Triglycerides/Glycerol Blanked 05976006190Recalls & reported problems
Roche Diagnostics GmbH · Class 1
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04015630928125), received between Sep 21, 2018 and Sep 21, 2018 — classified as 1 malfunction.
The most frequently reported specific device problem is “Non Reproducible Results” (1 report).
2 other recalls cover devices cleared under the same FDA submission (K873049); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Non Reproducible Results1
Patient problems
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 21, 2018Non Reproducible Results; Non Reproducible Results
THE CUSTOMER COMPLAINED OF LOW DISCREPANT RESULTS FOR 3 PATIENT SAMPLES TESTED FOR TRIGB TRIGLYCERIDES/GLYCEROL BLANKED (TRIGB) ON A COBAS 8000 C 702 MODULE. PATIENT 1 INITIAL TRIGB RESULT WAS 319 MG/DL. THIS RESULT WAS REPORTED OUTSIDE OF THE LABORATORY WHERE IT WAS QUESTIONED BY THE DOCTOR. ON (B)(6) 2018 THE SAMPLE WAS REPEATED AND THE RESULT WAS 232 MG/DL WITH A DATA FLAG. THE SAMPLE WAS REPEATED WITH AUTO-DILUTION AND THE RESULT WAS 4121 MG/DL. ON (B)(6) 2018 PATIENT 2 (FEMALE, (B)(6)) INITIAL TRIGB RESULT WAS 558 MG/DL. THIS RESULT WAS REPORTED OUTSIDE OF THE LABORATORY WHERE IT WAS QUESTIONED BY THE DOCTOR. ON (B)(6) 2018 THE SAMPLE WAS REPEATED AND THE RESULT WAS 514 MG/DL WITH A DATA FLAG. THE SAMPLE WAS REPEATED WITH AUTO-DILUTION AND THE RESULT WAS 3511 MG/DL. ON (B)(6) 2018 PATIENT 3 (FEMALE, (B)(6)) INITIAL TRIGB RESULT WAS 681 MG/DL. THIS RESULT WAS REPORTED OUTSIDE OF THE LABORATORY WHERE IT WAS QUESTIONED BY THE DOCTOR. THE SAMPLE WAS REPEATED WITH AUTO-DILUTION AND THE RESULT WAS 3337 MG/DL. THE REPEAT RESULTS USING AUTO-DILUTION WERE BELIEVED TO BE CORRECT. NO ADVERSE EVENT OCCURRED. THE C702 MODULE SERIAL NUMBER WAS (B)(4). THE FIELD SERVICE ENGINEER (FSE) VISITE
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7898155 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K873049. One submission often covers many models, so check the product and lot details in each record.
- Z-1125-2019 · Dec 14, 2018 · Terminatedcobas c 111 with ISE analyzers analyzer used in the following assays: a)Creatinine plus ver.2 Catalog Number: 05401470190; b)Triglycerides Catalog Number: 04657594190 - Product
- Z-1930-2015 · May 7, 2015 · TerminatedTriglycerides/Glycerol Blanked. In vitro test for the quantitative determination of triglycerides in human serum and plasma or Roche/Hitachi MODULAR systems, and cobas c systems.
Other LIPASE HYDROLYSIS/GLYCEROL KINASE ENZYME, TRIGLYCERIDES devices
- Atellica CH Trig 11097591Siemens Healthcare Diagnostics Inc. · LIPASE HYDROLYSIS/GLYCEROL KINASE ENZYME, TRIGLYCERIDES1 recall1 report
- Atellica CH Trig_2 11537222Siemens Healthcare Diagnostics Inc. · LIPASE HYDROLYSIS/GLYCEROL KINASE ENZYME, TRIGLYCERIDES1 recall0 reports
- Triglycerides 08058687190Roche Diagnostics GmbH · LIPASE HYDROLYSIS/GLYCEROL KINASE ENZYME, TRIGLYCERIDES21 reports
- Triglycerides 20767107322Roche Diagnostics GmbH · LIPASE HYDROLYSIS/GLYCEROL KINASE ENZYME, TRIGLYCERIDES13 reports
- Triglycerides 05171407190Roche Diagnostics GmbH · LIPASE HYDROLYSIS/GLYCEROL KINASE ENZYME, TRIGLYCERIDES11 reports
- Triglycerides 04657594190Roche Diagnostics GmbH · LIPASE HYDROLYSIS/GLYCEROL KINASE ENZYME, TRIGLYCERIDES1 report
- AU OSR6130Beckman Coulter, Inc. · Lipase Hydrolysis/Glycerol Kinase Enzyme, Triglycerides1 report
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.